EF Hutton Reiterates Buy on Glimpse Group, Maintains $7 Price Target
EF Hutton analyst Michael Albanese reiterates Glimpse Group (NASDAQ:VRAR) with a Buy and maintains $7 price target.
Earnings Scheduled For February 14, 2023
Companies Reporting Before The Bell
• WESCO International (NYSE:WCC) is projected to report quarterly earnings at $3.79 per share on revenue of $5.37 billion.
12 Information Technology Stocks Moving In Tuesday’s Intraday Session
Gainers WaveDancer (NASDAQ:WAVD) stock increased by 25.0% to $0.81 during Tuesday’s regular session. Trading volume for WaveDancer’s stock…
12 Information Technology Stocks Moving In Friday’s Intraday Session
Gainers SoundHound AI (NASDAQ:SOUN) stock increased by 36.1% to $2.11 during Friday’s regular session. Trading volume for SoundHound…
Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 325 companies set new 52-week lows.
Immersive Health Group, Subsidiary Of The Glimpse Group, Announces The Integration Of InciteVR’s Technology And IP, Propelling Its Immersive Healthcare Capabilities
Assignment of Technologies and Industry Hires Significantly Expand Immersive Health Group's Technological Capabilities in the Clinical and Nurse Training Segment NEW YORK, NY / ACCESSWIRE / November 28, 2022
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell
• Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million.
Glimpse Group Subsidiary Sector 5 Digital Provides Interactive 3D Gamified Experience With Multiple Customized NFTs For A Fortune 50 Global Technology Company Partner Event
The Glimpse Group, Inc. ("Glimpse") (NASDAQ:VRAR) (FSE:9DR), a diversified Virtual Reality ("VR") and Augmented Reality ("AR") platform company providing enterprise-focused VR and
Here’s Why This Analyst Thinks That Glimpse Group Did A Nice Job
EF Hutton analyst Ben Piggott had a chance to catch up with The Glimpse Group, Inc (NASDAQ: VRAR) management following its recent announcement of two significant acquisitions: Brightline and PulpoAR.